Test Bank:
v
Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Latest
v v v v v v v v
Edition, 2024
v v
, Table of Contents v v
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ............................................ 3
v v v v v v v v
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics .................................................................... 13
v v v v
Chapter4: Pharmacogenetics and Pharmacogenomics ................................................................................ 25
v v v
Chapter 5: Pharmacology Across the Life Span ........................................................................................ 30
v v v v v v
Chapter 6: Drug-Therapy Prescribing in Special Populations ................................................................... 36
v v v v v v
Chapter 7: Drug Development and Approval ............................................................................................ 45
v v v v v
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-Substance
v v v v v v v v v
Prescribing Chapter 10: Antibiotic Stewardship......................................................................................... 51
v v v v v
Chapter 11: Applied Calculations for Prescribing ..................................................................................... 58
v v v v v
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-Focused
v v v v v v v v v
Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapter 14:
v v v v v v v v v v v v
Pharmacotherapy for Eye Conditions ......................................................................................................... 67
v v v v
Chapter 15: Pharmacotherapy for Skin Conditions ................................................................................... 74
v v v v v
Chapter 16: Pharmacotherapy for Neurologic Conditions......................................................................... 81
v v v v v
Chapter 17: Pharmacotherapy for Cardiovascular Conditions .................................................................. 94
v v v v v
Chapter 18: Pharmacotherapy for Respiratory Conditions...................................................................... 106
v v v v v
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional
v v v v v v v v
Support ...................................................................................................................................................... 117
v
Chapter 20: Pharmacotherapy for Genitourinary Conditions .................................................................. 128
v v v v v
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders ........................ 133
v v v v v v v v v
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions ............................. 146
v v v v v v v
Chapter 23: Therapeutic Applications of Immunology and Vaccines ................................................... 158
v v v v v v v
Chapter 24: Pharmacotherapy for Endocrine Disorders .......................................................................... 163
v v v v v
Chapter 25: Pharmacotherapy for Hematologic Disorders ...................................................................... 174
v v v v v
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist ................................... 190
v v v v v v v v
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions................................................. 196
v v v v v v v
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions ...................................................... 211
v v v v v v v
Chapter 29: Pharmacotherapy Related to Transgender Care .................................................................. 217
v v v v v v
Chapter 30: Antimicrobial Pharmacotherapy ........................................................................................... 224
v v v
Chapter 31: Antiretroviral Pharmacotherapy ............................................................................................ 235
v v v
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and
v v v v v v v v v
Neurocognitive Conditions ....................................................................................................................... 247
v v
Chapter 33: Pharmacotherapy for Pain Management .............................................................................. 257
v v v v v
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance ....................................... 267
v v v v v v v v v
Chapter 35: Over-the-Counter Medications ............................................................................................. 283
v v v
Chapter 36: Pharmacotherapy for Obesity ............................................................................................... 291
v v v v
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
v v v v v v v v
MULTIPLE CHOICE v
• What is the primary purpose of the nursing assessment?
v v v v v v v v
A. Identifying underlying pathologic conditions v v v
B. Assisting the physician in identifying medical conditions v v v v v v
C. Determining the patients mental status v v v v
D. Exploring patient responses to health problems v v v v v
ANS: D v
A nursing assessment is done to identify the patients response to health
v v v v v v v v v v v
problems. During the nursing assessment phase, a comprehensive
v v v v v v v v
information base is developed through a physical examination, nursing
v v v v v v v v v
history, medication history, and professional observation. Identifying
v v v v v v v
underlying pathologic conditions and assisting the physician in identifying
v v v v v v v v v
medical conditions is not part of the nursing process. Determining the
v v v v v v v v v v v
patients mental status is one part of the nursing assessment, but it is
v v v v v v v v v v v v v
not the primary purpose.
v v v v
DIF: Cognitive Level: Comprehension
v v v
REF: dm 36 OBJ: 1 | 3 TOP: Nursing
v v v v v v v v v
Process Step: Assessment
v v v
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
v v v v v v v v
• What is the basis of the NANDA I taxonomy?
v v v v v v v v
A. Functional health patterns v v
B. Human response patterns v v
C. Basic human needs v v
D. Pathophysiologic needs v
ANS: B v
The NANDA I taxonomy identifies human response patterns.
v v v v v v v
Functional components of health patterns are limited to activity, fluid
v v v v v v v v v v
volume, nutrition, self care, and sensory perception. Basic human needs
v v v v v v v v v v
comprise less than merely health patterns. Pathophysiologic needs are
v v v v v v v v v
vnot part of the scope of NANDA I.
v v v v v v v
, DIF: Cognitive Level: Knowledge
v v v
REF: pp. 37-38 OBJ: 5 TOP:
v v v v v v
Nursing Process Step: Diagnosis
v v v
MSC: NCLEX Client Needs Category: Physiological Integrity
v v v v v v
• Which task is included in the assessment step of the nursing process?
v v v v v v v v v v v
A. Establishing patient goals/outcomes v v
B. Implementing the nursing care plan (NCP) v v v v v
C. Measuring goal/outcome achievement v v
D. Collecting and communicating data v v v
ANS: D v
Data are collected and communicated in the assessment phase of the
v v v v v v v v v v
vnursing process. Establishing goals is the function of planning.
v v v v v v v v
Implementing the NCP is the function of implementation. Measuring
v v v v v v v v
voutcome achievement is the function of evaluation.
v v v v v v
DIF: Cognitive Level: Comprehension
v v v
REF: dm 36 OBJ: 2 | 3 TOP: Nursing
v v v v v v v v v
Process Step: Assessment
v v v
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
v v v v v v v v
• Which statement regarding nursing diagnoses is accurate?
v v v v v v
a. Nursing diagnoses remain the same for as long as the disease is present.
v v v v v v v v v v v v
b. Nursing diagnoses are written to identify disease states. v v v v v v v
c. Nursing diagnoses describe patient problems that nurses treat.
v v v v v v v
d. Nursing diagnoses identify causes related to illness. v v v v v v
ANS: C v
Diagnostic statements identify problems a nurse is independently able to
v v v v v v v v v
treat within the scope of professional practice. Nursing diagnoses vary
v v v v v v v v v v
with the changing condition of the patient. The response patterns are
v v v v v v v v v v v
unique to the patient and are not disease specific. Nursing diagnoses
v v v v v v v v v v v
describe the patients human response pattern.
v v v v v v
DIF: Cognitive Level: Comprehension
v v v
v
Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Latest
v v v v v v v v
Edition, 2024
v v
, Table of Contents v v
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ............................................ 3
v v v v v v v v
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics .................................................................... 13
v v v v
Chapter4: Pharmacogenetics and Pharmacogenomics ................................................................................ 25
v v v
Chapter 5: Pharmacology Across the Life Span ........................................................................................ 30
v v v v v v
Chapter 6: Drug-Therapy Prescribing in Special Populations ................................................................... 36
v v v v v v
Chapter 7: Drug Development and Approval ............................................................................................ 45
v v v v v
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-Substance
v v v v v v v v v
Prescribing Chapter 10: Antibiotic Stewardship......................................................................................... 51
v v v v v
Chapter 11: Applied Calculations for Prescribing ..................................................................................... 58
v v v v v
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-Focused
v v v v v v v v v
Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapter 14:
v v v v v v v v v v v v
Pharmacotherapy for Eye Conditions ......................................................................................................... 67
v v v v
Chapter 15: Pharmacotherapy for Skin Conditions ................................................................................... 74
v v v v v
Chapter 16: Pharmacotherapy for Neurologic Conditions......................................................................... 81
v v v v v
Chapter 17: Pharmacotherapy for Cardiovascular Conditions .................................................................. 94
v v v v v
Chapter 18: Pharmacotherapy for Respiratory Conditions...................................................................... 106
v v v v v
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional
v v v v v v v v
Support ...................................................................................................................................................... 117
v
Chapter 20: Pharmacotherapy for Genitourinary Conditions .................................................................. 128
v v v v v
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders ........................ 133
v v v v v v v v v
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions ............................. 146
v v v v v v v
Chapter 23: Therapeutic Applications of Immunology and Vaccines ................................................... 158
v v v v v v v
Chapter 24: Pharmacotherapy for Endocrine Disorders .......................................................................... 163
v v v v v
Chapter 25: Pharmacotherapy for Hematologic Disorders ...................................................................... 174
v v v v v
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist ................................... 190
v v v v v v v v
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions................................................. 196
v v v v v v v
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions ...................................................... 211
v v v v v v v
Chapter 29: Pharmacotherapy Related to Transgender Care .................................................................. 217
v v v v v v
Chapter 30: Antimicrobial Pharmacotherapy ........................................................................................... 224
v v v
Chapter 31: Antiretroviral Pharmacotherapy ............................................................................................ 235
v v v
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and
v v v v v v v v v
Neurocognitive Conditions ....................................................................................................................... 247
v v
Chapter 33: Pharmacotherapy for Pain Management .............................................................................. 257
v v v v v
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance ....................................... 267
v v v v v v v v v
Chapter 35: Over-the-Counter Medications ............................................................................................. 283
v v v
Chapter 36: Pharmacotherapy for Obesity ............................................................................................... 291
v v v v
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
v v v v v v v v
MULTIPLE CHOICE v
• What is the primary purpose of the nursing assessment?
v v v v v v v v
A. Identifying underlying pathologic conditions v v v
B. Assisting the physician in identifying medical conditions v v v v v v
C. Determining the patients mental status v v v v
D. Exploring patient responses to health problems v v v v v
ANS: D v
A nursing assessment is done to identify the patients response to health
v v v v v v v v v v v
problems. During the nursing assessment phase, a comprehensive
v v v v v v v v
information base is developed through a physical examination, nursing
v v v v v v v v v
history, medication history, and professional observation. Identifying
v v v v v v v
underlying pathologic conditions and assisting the physician in identifying
v v v v v v v v v
medical conditions is not part of the nursing process. Determining the
v v v v v v v v v v v
patients mental status is one part of the nursing assessment, but it is
v v v v v v v v v v v v v
not the primary purpose.
v v v v
DIF: Cognitive Level: Comprehension
v v v
REF: dm 36 OBJ: 1 | 3 TOP: Nursing
v v v v v v v v v
Process Step: Assessment
v v v
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
v v v v v v v v
• What is the basis of the NANDA I taxonomy?
v v v v v v v v
A. Functional health patterns v v
B. Human response patterns v v
C. Basic human needs v v
D. Pathophysiologic needs v
ANS: B v
The NANDA I taxonomy identifies human response patterns.
v v v v v v v
Functional components of health patterns are limited to activity, fluid
v v v v v v v v v v
volume, nutrition, self care, and sensory perception. Basic human needs
v v v v v v v v v v
comprise less than merely health patterns. Pathophysiologic needs are
v v v v v v v v v
vnot part of the scope of NANDA I.
v v v v v v v
, DIF: Cognitive Level: Knowledge
v v v
REF: pp. 37-38 OBJ: 5 TOP:
v v v v v v
Nursing Process Step: Diagnosis
v v v
MSC: NCLEX Client Needs Category: Physiological Integrity
v v v v v v
• Which task is included in the assessment step of the nursing process?
v v v v v v v v v v v
A. Establishing patient goals/outcomes v v
B. Implementing the nursing care plan (NCP) v v v v v
C. Measuring goal/outcome achievement v v
D. Collecting and communicating data v v v
ANS: D v
Data are collected and communicated in the assessment phase of the
v v v v v v v v v v
vnursing process. Establishing goals is the function of planning.
v v v v v v v v
Implementing the NCP is the function of implementation. Measuring
v v v v v v v v
voutcome achievement is the function of evaluation.
v v v v v v
DIF: Cognitive Level: Comprehension
v v v
REF: dm 36 OBJ: 2 | 3 TOP: Nursing
v v v v v v v v v
Process Step: Assessment
v v v
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
v v v v v v v v
• Which statement regarding nursing diagnoses is accurate?
v v v v v v
a. Nursing diagnoses remain the same for as long as the disease is present.
v v v v v v v v v v v v
b. Nursing diagnoses are written to identify disease states. v v v v v v v
c. Nursing diagnoses describe patient problems that nurses treat.
v v v v v v v
d. Nursing diagnoses identify causes related to illness. v v v v v v
ANS: C v
Diagnostic statements identify problems a nurse is independently able to
v v v v v v v v v
treat within the scope of professional practice. Nursing diagnoses vary
v v v v v v v v v v
with the changing condition of the patient. The response patterns are
v v v v v v v v v v v
unique to the patient and are not disease specific. Nursing diagnoses
v v v v v v v v v v v
describe the patients human response pattern.
v v v v v v
DIF: Cognitive Level: Comprehension
v v v
